154 related articles for article (PubMed ID: 34705107)
1. Intraoperative frozen section analysis of para-aortic lymph nodes after neoadjuvant FOLFIRINOX: will it soon become useless?
Garnier J; Magallon C; Ewald J; Palen A; Marchese U; Delpero JR; Turrini O
Langenbecks Arch Surg; 2022 May; 407(3):1065-1071. PubMed ID: 34705107
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment.
van Roessel S; van Veldhuisen E; Klompmaker S; Janssen QP; Abu Hilal M; Alseidi A; Balduzzi A; Balzano G; Bassi C; Berrevoet F; Bonds M; Busch OR; Butturini G; Del Chiaro M; Conlon KC; Falconi M; Frigerio I; Fusai GK; Gagnière J; Griffin O; Hackert T; Halimi A; Klaiber U; Labori KJ; Malleo G; Marino MV; Mortensen MB; Nikov A; Lesurtel M; Keck T; Kleeff J; Pandé R; Pfeiffer P; Pietrasz D; Roberts KJ; Sa Cunha A; Salvia R; Strobel O; Tarvainen T; Bossuyt PM; van Laarhoven HWM; Wilmink JW; Groot Koerkamp B; Besselink MG;
JAMA Oncol; 2020 Nov; 6(11):1733-1740. PubMed ID: 32910170
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic ductal adenocarcinoma and paraaortic lymph nodes metastases: The accuracy of intraoperative frozen section.
Doussot A; Bouvier A; Santucci N; Lequeu JB; Cheynel N; Ortega-Deballon P; Rat P; Facy O
Pancreatology; 2019 Jul; 19(5):710-715. PubMed ID: 31174978
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of pancreatic adenocarcinoma that was not resected because of isolated para-aortic lymph node involvement.
Marchese U; Ewald J; Gilabert M; Delpero JR; Turrini O
J Visc Surg; 2019 Apr; 156(2):97-101. PubMed ID: 30026012
[TBL] [Abstract][Full Text] [Related]
5. Para-aortic lymph node metastasis detected intraoperatively by systematic frozen section examination in pancreatic head adenocarcinoma: is resection improving the prognosis?
Collard M; Voron T; Svrcek M; Ahmed O; Balladur P; Hor T; André T; Paye F
HPB (Oxford); 2020 Nov; 22(11):1604-1612. PubMed ID: 32179009
[TBL] [Abstract][Full Text] [Related]
6. CT evaluation after neoadjuvant FOLFIRINOX chemotherapy for borderline and locally advanced pancreatic adenocarcinoma.
Wagner M; Antunes C; Pietrasz D; Cassinotto C; Zappa M; Sa Cunha A; Lucidarme O; Bachet JB
Eur Radiol; 2017 Jul; 27(7):3104-3116. PubMed ID: 27896469
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant Radiotherapy After (m)FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: A TAPS Consortium Study.
Janssen QP; van Dam JL; Prakash LR; Doppenberg D; Crane CH; van Eijck CHJ; Ellsworth SG; Jarnagin WR; O'Reilly EM; Paniccia A; Reyngold M; Besselink MG; Katz MHG; Tzeng CD; Zureikat AH; Groot Koerkamp B; Wei AC;
J Natl Compr Canc Netw; 2022 Jul; 20(7):783-791.e1. PubMed ID: 35830887
[TBL] [Abstract][Full Text] [Related]
8. Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer.
Ferrone CR; Marchegiani G; Hong TS; Ryan DP; Deshpande V; McDonnell EI; Sabbatino F; Santos DD; Allen JN; Blaszkowsky LS; Clark JW; Faris JE; Goyal L; Kwak EL; Murphy JE; Ting DT; Wo JY; Zhu AX; Warshaw AL; Lillemoe KD; Fernández-del Castillo C
Ann Surg; 2015 Jan; 261(1):12-7. PubMed ID: 25599322
[TBL] [Abstract][Full Text] [Related]
9. Surgery Improves Survival After Neoadjuvant Therapy for Borderline and Locally Advanced Pancreatic Cancer: A Single Institution Experience.
Rangelova E; Wefer A; Persson S; Valente R; Tanaka K; Orsini N; Segersvärd R; Arnelo U; Del Chiaro M
Ann Surg; 2021 Mar; 273(3):579-586. PubMed ID: 30946073
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX.
Michelakos T; Pergolini I; Castillo CF; Honselmann KC; Cai L; Deshpande V; Wo JY; Ryan DP; Allen JN; Blaszkowsky LS; Clark JW; Murphy JE; Nipp RD; Parikh A; Qadan M; Warshaw AL; Hong TS; Lillemoe KD; Ferrone CR
Ann Surg; 2019 Apr; 269(4):733-740. PubMed ID: 29227344
[TBL] [Abstract][Full Text] [Related]
11. Para-aortic lymph node sampling in pancreatic head adenocarcinoma.
Schwarz L; Lupinacci RM; Svrcek M; Lesurtel M; Bubenheim M; Vuarnesson H; Balladur P; Paye F
Br J Surg; 2014 Apr; 101(5):530-8. PubMed ID: 24633831
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of paraaortic lymph node metastases in patients with ductal adenocarcinoma of the pancreatic head.
Petrova E; Mazzella E; Trojan J; Koch C; Schulze F; Bechstein WO; Schnitzbauer AA
Eur J Surg Oncol; 2023 May; 49(5):996-1000. PubMed ID: 36586788
[TBL] [Abstract][Full Text] [Related]
13. Feasibility, Safety, and Efficacy of Aggressive Multimodal Management of Elderly Patients With Pancreatic Ductal Adenocarcinoma.
Qiao G; Fong ZV; Bolm L; Fernandez Del-Castillo C; Ferrone CR; Servin-Rojas M; Pathak P; Lau-Min K; Allen JN; Blaszkowsky LS; Clark JW; Parikh AR; Ryan DP; Weekes CD; Roberts HM; Wo JY; Hong TS; Lillemoe KD; Qadan M
Ann Surg; 2024 Jul; 280(1):118-125. PubMed ID: 37830225
[TBL] [Abstract][Full Text] [Related]
14. The prognostic impact of para-aortic lymph node metastasis in pancreatic cancer: A systematic review and meta-analysis.
Paiella S; Sandini M; Gianotti L; Butturini G; Salvia R; Bassi C
Eur J Surg Oncol; 2016 May; 42(5):616-24. PubMed ID: 26916137
[TBL] [Abstract][Full Text] [Related]
15. Impact of para aortic lymph node removal on survival following resection for pancreatic adenocarcinoma.
Sillesen M; Hansen CP; Burgdorf SK; Dencker EE; Krohn PS; Gisela Kollbeck SL; Stender MT; Storkholm JH
BMC Surg; 2023 Aug; 23(1):214. PubMed ID: 37528360
[TBL] [Abstract][Full Text] [Related]
16. A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma.
Hosein PJ; Macintyre J; Kawamura C; Maldonado JC; Ernani V; Loaiza-Bonilla A; Narayanan G; Ribeiro A; Portelance L; Merchan JR; Levi JU; Rocha-Lima CM
BMC Cancer; 2012 May; 12():199. PubMed ID: 22642850
[TBL] [Abstract][Full Text] [Related]
17. [A Case of Long-Term Survival after Resection of Pancreatic Ductal Adenocarcinoma with Para-Aortic Lymph Node Metastasis].
Otake H; Takizawa K; Nagaro H; Toge K; Hirose Y; Ishikawa H; Miura K; Ichikawa H; Hanyu T; Nagahashi M; Shimada Y; Ishikawa T; Sakata J; Kobayashi T; Wakai T
Gan To Kagaku Ryoho; 2021 Dec; 48(13):2002-2004. PubMed ID: 35045474
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative Radiation Therapy (IORT) for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (BR/LA PDAC) in the Era of Modern Neoadjuvant Treatment: Short-Term and Long-Term Outcomes.
Harrison JM; Wo JY; Ferrone CR; Horick NK; Keane FK; Qadan M; Lillemoe KD; Hong TS; Clark JW; Blaszkowsky LS; Allen JN; Castillo CF
Ann Surg Oncol; 2020 May; 27(5):1400-1406. PubMed ID: 31758284
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative paraaortic lymph node sampling during resection for pancreatic cancer: evolving role in the modern chemotherapy era.
Kazami Y; Oba A; Ono Y; Sato T; Inoue Y; Saiura A; Takahashi Y; Ito H
HPB (Oxford); 2023 Oct; 25(10):1169-1178. PubMed ID: 37357111
[TBL] [Abstract][Full Text] [Related]
20. Multiparametric MRI for prediction of treatment response to neoadjuvant FOLFIRINOX therapy in borderline resectable or locally advanced pancreatic cancer.
Kang JH; Lee SS; Kim JH; Byun JH; Kim HJ; Yoo C; Kim KP; Ryoo BY; Kim SC
Eur Radiol; 2021 Feb; 31(2):864-874. PubMed ID: 32813104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
